Expertise in
3
conditions

Dr. Arafat H. Tfayli

Oncology
South Wellness Community Health Clinic
1122 NE 13th St, 
Oklahoma City, OK 
Accepting New Patients
Expertise in
3
conditions
South Wellness Community Health Clinic
1122 NE 13th St, 
Oklahoma City, OK 

Overview

Arafat Tfayli is an Oncologist practicing medicine in Oklahoma City, Oklahoma.

Dr. Tfayli is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Breast Cancer, Lung Cancer, Tissue Biopsy, and Orchiectomy.

He is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials. Dr. Tfayli is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in OK

Hospital Affiliations

Regional West Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

South Wellness Community Health Clinic
1122 NE 13th St, Oklahoma City, OK 73117
Other Locations
Regional West Medical Center
4021 Avenue B, Scottsbluff, NE 69361

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Enrollment Status: Completed
Publish Date: October 28, 2021
Intervention Type: Drug
Study Phase: Phase 3
Randomized Multicenter Study to Compare the Effectiveness and Safety of Erlotinib and Pemetrexed as Maintenance Therapy of Advanced Non-Squamous Non-Small Cell Lung Cancer
Randomized Multicenter Study to Compare the Effectiveness and Safety of Erlotinib and Pemetrexed as Maintenance Therapy of Advanced Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: March 05, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

100 Total Publications

Impact of Lack of Access to Immunotherapy on Survival in Stage IV Non-Small Cell Lung Cancer: A Multicenter Retrospective Study From Lebanon.
Impact of Lack of Access to Immunotherapy on Survival in Stage IV Non-Small Cell Lung Cancer: A Multicenter Retrospective Study From Lebanon.
Journal: JCO global oncology
Published: July 22, 2026
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Ou Health Stephenson Cancer Center-Gynecologic Cancer Clinic

800 NE 10th St Ste 2100, 
Oklahoma City, OK 
 (0.9 miles away)
405-271-8707
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joan Walker is an Oncologist practicing medicine in Oklahoma City, Oklahoma. She has been practicing medicine for over 44 years. Dr. Walker is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Sertoli-Leydig Cell Tumor, Gamma Knife Radiosurgery, and Ureteroscopy. Dr. Walker is currently accepting new patients.

Expertise in
54
conditions
Expertise in
54
conditions
Referral may be required

SSM Health Cancer Care

3525 N.W. 56th St., Suite 100D, 
Oklahoma City, OK 
 (5.9 miles away)
405-942-9200
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Board certified in both medical oncology and internal medicine, Aleda Toma, MD is a member of Cancer Specialists of Oklahoma, a part of SSM Health St. Anthony. She cares for patients in north Oklahoma City and surrounding areas, as well as Shawnee, Okla. Dr. Toma is highly rated in 54 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Toma is board certified in Oklahoma State Board Of Medical Licensure & Supervision, American Board Of Internal Medicine/Medical Oncology , American Board Of Internal Medicine , Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Toma is currently accepting new patients.

Expertise in
80
conditions
Expertise in
80
conditions
Referral may be required

Mercy Hospital Oklahoma City Inc.

4300 W Memorial Rd, 
Oklahoma City, OK 
 (10.5 miles away)
405-751-4343
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Keefer is an Oncologist practicing medicine in Oklahoma City, Oklahoma. Dr. Keefer is highly rated in 80 conditions, according to our data. His clinical expertise encompasses Chondrosarcoma, Osteosarcoma, Ewing Sarcoma, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Keefer is currently accepting new patients.

Frequently Asked Questions about Dr. Arafat H. Tfayli

How do I make an appointment with Dr. Arafat H. Tfayli?

You can book an appointment with Dr. Arafat H. Tfayli by calling their office at 405-271-8299. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Arafat H. Tfayli a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arafat H. Tfayli is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Arafat H. Tfayli specialize in?

While Dr. Arafat H. Tfayli is a Oncology, they have specific expertise in Lung Adenocarcinoma, Breast Cancer, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Arafat H. Tfayli participate in research or clinical trials?

Yes. Dr. Arafat H. Tfayli has published 100 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Arafat H. Tfayli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Arafat H. Tfayli accept my insurance?

Dr. Arafat H. Tfayli accepts most major insurance plans, including Health Care Services Corporation and Medica. We recommend calling the office directly at 405-271-8299 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tfayli's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile